A 54-year-old man is diagnosed with type 2 diabetes after fasting plasma glucose of 8.2 mmol/L and HbA1c of 7.9 percent. He has no symptoms of hyperglycaemia, normal renal function, and no established cardiovascular disease. According to the most recent Diabetes Canada pharmacologic guidelines, what is the most appropriate initial pharmacologic management?